Post by account_disabled on Aug 30, 2023 4:48:19 GMT
Featured image: An electron microscope image shows quartz fibers with carbon nanotubes after epoxidation. Experiments showed epoxidation appears to give the filters their absorptive quality.
CVaccines genetically tailored to the specific mutations of patients’ cancer cells have proven effective in small clinical trials. Research groups conducing separate studies in the US and Germany published promising results,
Generating cautious optimism that the approach could be a Switzerland Mobile Number List game-changer for cancer treatment. Like vaccines used against infectious diseases, the treatment works by using components of the target disease—in this case cancer cells—to stimulate an immune response. The specific makeup of each vaccine is tailored to the patient and their cancer cells’ unique genetic mutations. We spoke with Ugur Sahin, lead researcher of one of the studies, to learn more:
ResearchGate: Why does cancer treatment need to be personalized?
Ugur Sahin: Every human being is unique, and so is each cancer. Conventional treatments do not account for this, but instead go for the minimal common denominator.
RG: What’s the greatest challenge in developing personalized vaccines?
Sahin: One of the greatest challenges is selecting the right cancer-specific molecules that induce a strong immune response against the tumor when used in a vaccine. redit: Barron Research Group/Rice University.
CVaccines genetically tailored to the specific mutations of patients’ cancer cells have proven effective in small clinical trials. Research groups conducing separate studies in the US and Germany published promising results,
Generating cautious optimism that the approach could be a Switzerland Mobile Number List game-changer for cancer treatment. Like vaccines used against infectious diseases, the treatment works by using components of the target disease—in this case cancer cells—to stimulate an immune response. The specific makeup of each vaccine is tailored to the patient and their cancer cells’ unique genetic mutations. We spoke with Ugur Sahin, lead researcher of one of the studies, to learn more:
ResearchGate: Why does cancer treatment need to be personalized?
Ugur Sahin: Every human being is unique, and so is each cancer. Conventional treatments do not account for this, but instead go for the minimal common denominator.
RG: What’s the greatest challenge in developing personalized vaccines?
Sahin: One of the greatest challenges is selecting the right cancer-specific molecules that induce a strong immune response against the tumor when used in a vaccine. redit: Barron Research Group/Rice University.